Replies to post #233219 on Biotech Values

[DewDiligence]

ALT finally starts phase-2 HBV trial announced six months ago:

https://www.globenewswire.com/news-release/2020/12/30/2151700/0/en/Altimmune-Begins-Multinational-Phase-2-Clinical-Trial-of-HepTcellTM-a-Novel-Immunotherapeutic-for-the-Treatment-of-Chronic-Hepatitis-B.html

I presume the delay in enrolling the first patient was due to COVID.